Health authority approval given to Omya for API production
Swiss company Omya’s production site in Kemalpaşa, Turkey, has gained health authority approval to produce GMP-compliant pharmaceutical ingredients.
Archives for April 27, 2023
Neuraxpharm and API specialist Inke part with help of private equity company
Neuraxapharm Group, a European-based pharmaceutical company that focuses on central nervous system (CNS) announced last week that it had signed a binding agreement to divest API developer and manufacturer company, Inke, to private equity manager...
Greenphire launches app expanding convenience for patients in clinical trials
Greenphire, a company that finds solutions for companies wanting to run clinical trials has launched a new patient-facing digital platform.